At RSSL, we were responsible for release testing essential components for the vaccine and providing analytical support to meet the requirements of the client. Due to the high production demand, we had to complete all analyses within seven days from receipt of sample. To meet these timelines, we deployed a multidisciplinary team of scientists across various laboratories involved in raw materials testing.
Due to the nature of the industry over the past few years, priorities and timescales changed rapidly. However, we were able to leverage our capabilities to offer analytical services as well as specialist equipment to meet the needs of the client. Through our commitment to growth, innovation, and adaptation, we were able to keep up with an uncertain and fast-changing world, identifying opportunities where the client could streamline their procedures. In fact, our ability to communicate and collaborate with the client and third parties became a key factor in the success of this project.